Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2023 ) > List of Articles


Need for larger cohorts and standardized tools to study diseases in newborn infants

Citation Information :

DOI: 10.5005/newborn-2-3-iv

License: CC BY-NC 4.0

Published Online: 26-09-2023

Copyright Statement:  Copyright © 2023; The Author(s).


PDF Share
  1. Transfusion of Prematures Trial. Vol. 2018 (
  2. Barfield WD, Committee On Fetus and Newborn. Standard terminology for fetal, infant, and perinatal deaths. Pediatrics 2016;137.
  3. Assou S, et al. Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications. Hum Reprod Update 2011;17:272–290.
  4. Li Q, et al. Large-scale analysis of de novo mutations identifies risk genes for female infertility characterized by oocyte and early embryo defects. Genome Biol 2023;24:68.
  5. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500–1507.
  6. Adams Waldorf KM, McAdams RM. Influence of infection during pregnancy on fetal development. Reproduction 2013;146:R151–162.
  7. Romero R, et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21–39.
  8. Hennekam RC, et al. Elements of morphology: general terms for congenital anomalies. Am J Med Genet A 2013;161A:2726–2733.
  9. Reichel TF, et al. Fetal central nervous system biometry on MR imaging. AJR Am J Roentgenol 2003;180:1155–1158.
  10. Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med 2020;383:2255–2273.
  11. Mellembakken JR, et al. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 2001;38:394–398.
  12. Pawar R, et al. Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children (Basel) 2021;8.
  13. Pietrasanta C, et al. Vascular endothelium in neonatal sepsis: basic mechanisms and translational opportunities. Front Pediatr 2019;7:340.
  14. Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010;37:439–479.
  15. Celik IH, Hanna M, Canpolat FE, Mohan P. Diagnosis of neonatal sepsis: the past, present and future. Pediatr Res 2022;91:337–350.
  16. Peila C, et al. Extrauterine growth restriction: definitions and predictability of outcomes in a cohort of very low birth weight infants or preterm neonates. Nutrients 2020;12.
  17. Fenton TR, et al. “Extrauterine growth restriction” and “postnatal growth failure” are misnomers for preterm infants. J Perinatol 2020;40:704–714.
  18. Lan S, et al. Extrauterine growth restriction in preterm infants: postnatal growth pattern and physical development outcomes at age 3-6 years. Front Pediatr 2022;10:945422.
  19. Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr 2016;10:67–83.
  20. Zozaya C, Diaz C, Saenz de Pipaon M. How should we define postnatal growth restriction in preterm infants? Neonatology 2018;114:177–180.
  21. Panagiotakaki E, et al. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults. Brain 2010;133:3598–3610.
  22. Boateng GO, Neilands TB, Frongillo EA, Melgar-Quinonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health 2018;6:149.
  23. Denny JC, Collins FS. Precision medicine in 2030-seven ways to transform healthcare. Cell 2021;184:1415–1419.
  24. Allgaier J, Mulansky L, Draelos RL, Pryss R. How does the model make predictions? A systematic literature review on the explainability power of machine learning in healthcare. Artif Intell Med 2023;143:102616.
  25. Deawjaroen K, Sillabutra J, Poolsup N, Stewart D, Suksomboon N. Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug-related problems: a systematic review of clinical prediction models and risk assessment tools. Br J Clin Pharmacol 2022;88:1613–1629.
  26. Jung-Poppe L, et al. Systematic review of risk factors assessed in predictive scoring tools for drug-related problems in inpatients. J Clin Med 2022;11.
  27. Howe Iii EG, Elenberg F. Ethical challenges posed by big data. Innov Clin Neurosci 2020;17:24–30.
  28. Toledano MB, Smith RB, Brook JP, Douglass M, Elliott P. How to establish and follow up a large prospective cohort study in the 21st Century–Lessons from UK COSMOS. PLoS One 2015;10:e0131521.
  29. Maheshwari A, Lui K, Motta M. Understanding the impact of maternal health on neonatal disease: a new horizon. Newborn 2023;1:iv–vi.
  30. Mutair AA, et al. The effective strategies to avoid medication errors and improving reporting systems. Medicines (Basel) 2021;8.
  31. Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther 2011;16:170–184.
  32. Allegaert K, van den Anker JN. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol 2015;80:788–795.
  33. Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology 2015;40:61–87.
  34. Allegaert K, van den Anker J. Neonatal drug therapy: the first frontier of therapeutics for children. Clin Pharmacol Ther 2015;98:288–297.
  35. Ward ZJ, et al. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis. Lancet Oncol 2020;21:1077–1088.
  36. Mehta VK, Deb PS, Rao DS. Application of computer techniques in medicine. Med J Armed Forces India 1994;50:215–218.
  37. Ahuja AS. The impact of artificial intelligence in medicine on the future role of the physician. Peer J 2019;7:e7702.
  38. Lee D, Yoon SN. Application of artificial intelligence-based technologies in the healthcare industry: opportunities and challenges. Int J Environ Res Public Health 2021;18.
  39. Witt WP, Weiss AJ, Elixhauser A. Overview of hospital stays for children in the united states, 2012. in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (Rockville (MD), 2006).
  40. Quality, AfHRa. Healthcare Cost & Utilization Project (HCUP): Kids' Inpatient Database (KID). (Department of Health and Human Services (HHS). Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, 1997).
  41. Statistics, NCfH. International classification of diseases, Ninth Revision (ICD-9). Vol. 2023 (U.S. Department of Health & Human Services, Atlanta, Georgia, 2022).
  42. King MS, Lipsky MS, Sharp L. Expert agreement in current procedural terminology evaluation and management coding. Arch Intern Med 2002;162:316–320.
  43. Services, CfMM. Medicaid services. Vol. 2023 (Centers for Medicare & Medicaid Services, Baltimore, MD, 2023).
  44. Commerce, USDo. ZIP Code Tabulation Areas (ZCTAs). Vol. 2023 (, 2020).
  45. WHO I. The Global Health Observatory. Vol. 2023 (WHO, Int., Geneva, Switzerland, 2023).
  46. Society NG. United States Regions. Vol. 2023 (National Geographic Society, Washington, DC, 2023).
  47. Alam MZ, et al. Epidemiological study of congenital anomalies and risk factors in newborn infants at a tertiary care hospital in Bangladesh. Newborn 2023;2(3):185–190.
  48. Garg PMG, et al. Clinical correlates of cholestasis in preterm infants with surgical necrotizing enterocolitis. Newborn 2023;2(3):191–197.
  49. WHO I. Child growth standards/Standards/Weight-for-length/height. Vol. 2023 (WHO, Int., Geneva, Switzerland, 2023).
  50. Chauhan K, Bisht B, Kathuria K, Bisht R, Hatwal V. Z score analysis: a novel approach to interpretation of an erythrogram. Indian J Pathol Microbiol 2023;66:85–90.
  51. Nitasha Bagga N, et al. Extrauterine growth restriction: need for an accurate definition. Newborn 2023;2(3):198–202.
  52. Ong KK, et al. Which infancy growth parameters are associated with later adiposity? The cambridge baby growth study. Ann Hum Biol 2020;47:142–149.
  53. Santos S, et al. Associations of infant subcutaneous fat mass with total and abdominal fat mass at school-age: the generation R study. Paediatr Perinat Epidemiol 2016;30:511–520.
  54. Chetan C, Garegrat R, Hazarika J, Maheshwari A, Suryawanshi P. Point-of-care ultrasound to diagnose and monitor the course of necrotizing enterocolitis. Newborn 2023;2(3):203–213.
  55. Mishra V, et al. Imaging for diagnosis and assessment of necrotizing enterocolitis. Newborn (Clarksville) 2022;1:182–189.
  56. Chen Q, et al. Application of abdominal ultrasonography in surgical necrotizing enterocolitis: a retrospective study. Front Microbiol 2023;14:1211846.
  57. Janssen Lok M, et al. Value of abdominal ultrasound in management of necrotizing enterocolitis: a systematic review and meta-analysis. Pediatr Surg Int 2018;34:589–612.
  58. Epelman M, et al. Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. Radiographics 2007;27:285–305.
  59. Hiranandani M, Kaur I, Grover S. Umbilical cord blood gases: sampling, evaluation, and application for clinicians. Newborn 2023;2(3):214–221.
  60. Singh S, Maheshwari A, Namazova I, Benjamin JT, Wang Y. Respiratory syncytial virus infections in neonates: a persisting problem. Newborn 2023;2(3):222–234.
  61. Caserta MT, O'Leary ST, Munoz FM, Ralston SL, Committee On Infectious D. Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2023;152.
  62. Wennergren G, Kristjansson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 2001;18:1044–1058.
  63. Roff M, Slifirski O, Grooby E, Marzbanrad F, Malhotra A. Digital stethoscope use in neonates: a systematic review. Newborn 2023;2(3):235–243.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.